Search Reports
Categories
Categories

Global Cell Therapy Cdmo Market

Global Cell Therapy Cdmo Market Research Report 2025(Status and Outlook)

Report Code : SER7541
Published Date : 17 July, 1905 | No of Pages: 132

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
The cell therapy Contract Development and Manufacturing Organization (CDMO) market specializes in providing outsourced services for the development, manufacturing, and commercialization of cell-based therapies, including autologous and allogeneic treatments. These CDMOs support biopharmaceutical companies by offering expertise in process optimization, regulatory compliance, scalability, and quality control, addressing the complex challenges of cell therapy production. The market is driven by the increasing adoption of personalized medicine, advancements in gene and cell therapy technologies, and rising investments in regenerative medicine. Key players focus on expanding their capabilities in viral vector production, cryopreservation, and automation to improve efficiency and reduce costs. However, high development expenses, stringent regulatory requirements, and supply chain complexities pose challenges. Geographically, North America and Europe dominate due to strong biotech infrastructure, while Asia-Pacific shows rapid growth fueled by government initiatives and increasing R&D investments. Strategic partnerships between CDMOs and biotech firms are accelerating market expansion, with a growing emphasis on scalable and GMP-compliant manufacturing solutions to meet rising demand.

The global Cell Therapy Cdmo market size was estimated at USD 2648.23 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.45% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Cell Therapy Cdmo market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Cell Therapy Cdmo market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cell Therapy Cdmo market.
Global Cell Therapy Cdmo Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Charles River
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio

Market Segmentation (by Type)
Stem Cell
Non-Stem Cell

Market Segmentation (by Application)
Commercial
Academic Research
Others

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cell Therapy Cdmo Market
Overview of the regional outlook of the Cell Therapy Cdmo Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell Therapy Cdmo Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Cell Therapy Cdmo, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Cell Therapy Cdmo
      1.2 Key Market Segments
            1.2.1 Cell Therapy Cdmo Segment by Type
            1.2.2 Cell Therapy Cdmo Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Cell Therapy Cdmo Market Overview
      2.1 Global Market Overview
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Cell Therapy Cdmo Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Cell Therapy Cdmo Product Life Cycle
      3.3 Global Cell Therapy Cdmo Revenue Market Share by Company (2020-2025)
      3.4 Cell Therapy Cdmo Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.5 Cell Therapy Cdmo Company Headquarters, Area Served, Product Type
      3.6 Cell Therapy Cdmo Market Competitive Situation and Trends
            3.6.1 Cell Therapy Cdmo Market Concentration Rate
            3.6.2 Global 5 and 10 Largest Cell Therapy Cdmo Players Market Share by Revenue
            3.6.3 Mergers & Acquisitions, Expansion
  4 Cell Therapy Cdmo Value Chain Analysis
      4.1 Cell Therapy Cdmo Value Chain Analysis
      4.2 Midstream Market Analysis
      4.3 Downstream Customer Analysis
  5 The Development and Dynamics of Cell Therapy Cdmo Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Cell Therapy Cdmo Market Porter's Five Forces Analysis
  6 Cell Therapy Cdmo Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Cell Therapy Cdmo Market Size Market Share by Type (2020-2025)
      6.3 Global Cell Therapy Cdmo Market Size Growth Rate by Type (2021-2025)
  7 Cell Therapy Cdmo Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Cell Therapy Cdmo Market Size (M USD) by Application (2020-2025)
      7.3 Global Cell Therapy Cdmo Sales Growth Rate by Application (2020-2025)
  8 Cell Therapy Cdmo Market Segmentation by Region
      8.1 Global Cell Therapy Cdmo Market Size by Region
            8.1.1 Global Cell Therapy Cdmo Market Size by Region
            8.1.2 Global Cell Therapy Cdmo Market Size Market Share by Region
      8.2 North America
            8.2.1 North America Cell Therapy Cdmo Market Size by Country
            8.2.2 U.S.
            8.2.3 Canada
            8.2.4 Mexico
      8.3 Europe
            8.3.1 Europe Cell Therapy Cdmo Market Size by Country
            8.3.2 Germany
            8.3.3 France
            8.3.4 U.K.
            8.3.5 Italy
            8.3.6 Spain
      8.4 Asia Pacific
            8.4.1 Asia Pacific Cell Therapy Cdmo Market Size by Region
            8.4.2 China
            8.4.3 Japan
            8.4.4 South Korea
            8.4.5 India
            8.4.6 Southeast Asia
      8.5 South America
            8.5.1 South America Cell Therapy Cdmo Market Size by Country
            8.5.2 Brazil
            8.5.3 Argentina
            8.5.4 Columbia
      8.6 Middle East and Africa
            8.6.1 Middle East and Africa Cell Therapy Cdmo Market Size by Region
            8.6.2 Saudi Arabia
            8.6.3 UAE
            8.6.4 Egypt
            8.6.5 Nigeria
            8.6.6 South Africa
  9 Key Companies Profile
      9.1 Charles River
            9.1.1 Charles River Basic Information
            9.1.2 Charles River Cell Therapy Cdmo Product Overview
            9.1.3 Charles River Cell Therapy Cdmo Product Market Performance
            9.1.4 Charles River SWOT Analysis
            9.1.5 Charles River Business Overview
            9.1.6 Charles River Recent Developments
      9.2 The Discovery Labs
            9.2.1 The Discovery Labs Basic Information
            9.2.2 The Discovery Labs Cell Therapy Cdmo Product Overview
            9.2.3 The Discovery Labs Cell Therapy Cdmo Product Market Performance
            9.2.4 The Discovery Labs SWOT Analysis
            9.2.5 The Discovery Labs Business Overview
            9.2.6 The Discovery Labs Recent Developments
      9.3 BIOCENTRIQ
            9.3.1 BIOCENTRIQ Basic Information
            9.3.2 BIOCENTRIQ Cell Therapy Cdmo Product Overview
            9.3.3 BIOCENTRIQ Cell Therapy Cdmo Product Market Performance
            9.3.4 BIOCENTRIQ SWOT Analysis
            9.3.5 BIOCENTRIQ Business Overview
            9.3.6 BIOCENTRIQ Recent Developments
      9.4 FUJIFILM Diosynth Biotechnologies
            9.4.1 FUJIFILM Diosynth Biotechnologies Basic Information
            9.4.2 FUJIFILM Diosynth Biotechnologies Cell Therapy Cdmo Product Overview
            9.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy Cdmo Product Market Performance
            9.4.4 FUJIFILM Diosynth Biotechnologies Business Overview
            9.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments
      9.5 Exothera
            9.5.1 Exothera Basic Information
            9.5.2 Exothera Cell Therapy Cdmo Product Overview
            9.5.3 Exothera Cell Therapy Cdmo Product Market Performance
            9.5.4 Exothera Business Overview
            9.5.5 Exothera Recent Developments
      9.6 WuXi AppTec
            9.6.1 WuXi AppTec Basic Information
            9.6.2 WuXi AppTec Cell Therapy Cdmo Product Overview
            9.6.3 WuXi AppTec Cell Therapy Cdmo Product Market Performance
            9.6.4 WuXi AppTec Business Overview
            9.6.5 WuXi AppTec Recent Developments
      9.7 Pharmaron
            9.7.1 Pharmaron Basic Information
            9.7.2 Pharmaron Cell Therapy Cdmo Product Overview
            9.7.3 Pharmaron Cell Therapy Cdmo Product Market Performance
            9.7.4 Pharmaron Business Overview
            9.7.5 Pharmaron Recent Developments
      9.8 OBiO
            9.8.1 OBiO Basic Information
            9.8.2 OBiO Cell Therapy Cdmo Product Overview
            9.8.3 OBiO Cell Therapy Cdmo Product Market Performance
            9.8.4 OBiO Business Overview
            9.8.5 OBiO Recent Developments
      9.9 Cell Therapies
            9.9.1 Cell Therapies Basic Information
            9.9.2 Cell Therapies Cell Therapy Cdmo Product Overview
            9.9.3 Cell Therapies Cell Therapy Cdmo Product Market Performance
            9.9.4 Cell Therapies Business Overview
            9.9.5 Cell Therapies Recent Developments
      9.10 AGC Biologics
            9.10.1 AGC Biologics Basic Information
            9.10.2 AGC Biologics Cell Therapy Cdmo Product Overview
            9.10.3 AGC Biologics Cell Therapy Cdmo Product Market Performance
            9.10.4 AGC Biologics Business Overview
            9.10.5 AGC Biologics Recent Developments
      9.11 Cytiva
            9.11.1 Cytiva Basic Information
            9.11.2 Cytiva Cell Therapy Cdmo Product Overview
            9.11.3 Cytiva Cell Therapy Cdmo Product Market Performance
            9.11.4 Cytiva Business Overview
            9.11.5 Cytiva Recent Developments
      9.12 Helixmith
            9.12.1 Helixmith Basic Information
            9.12.2 Helixmith Cell Therapy Cdmo Product Overview
            9.12.3 Helixmith Cell Therapy Cdmo Product Market Performance
            9.12.4 Helixmith Business Overview
            9.12.5 Helixmith Recent Developments
      9.13 ThermoGenesis
            9.13.1 ThermoGenesis Basic Information
            9.13.2 ThermoGenesis Cell Therapy Cdmo Product Overview
            9.13.3 ThermoGenesis Cell Therapy Cdmo Product Market Performance
            9.13.4 ThermoGenesis Business Overview
            9.13.5 ThermoGenesis Recent Developments
      9.14 Anemocyte
            9.14.1 Anemocyte Basic Information
            9.14.2 Anemocyte Cell Therapy Cdmo Product Overview
            9.14.3 Anemocyte Cell Therapy Cdmo Product Market Performance
            9.14.4 Anemocyte Business Overview
            9.14.5 Anemocyte Recent Developments
      9.15 Thermo Fisher Scientific
            9.15.1 Thermo Fisher Scientific Basic Information
            9.15.2 Thermo Fisher Scientific Cell Therapy Cdmo Product Overview
            9.15.3 Thermo Fisher Scientific Cell Therapy Cdmo Product Market Performance
            9.15.4 Thermo Fisher Scientific Business Overview
            9.15.5 Thermo Fisher Scientific Recent Developments
      9.16 CBM
            9.16.1 CBM Basic Information
            9.16.2 CBM Cell Therapy Cdmo Product Overview
            9.16.3 CBM Cell Therapy Cdmo Product Market Performance
            9.16.4 CBM Business Overview
            9.16.5 CBM Recent Developments
      9.17 Bio Elpida
            9.17.1 Bio Elpida Basic Information
            9.17.2 Bio Elpida Cell Therapy Cdmo Product Overview
            9.17.3 Bio Elpida Cell Therapy Cdmo Product Market Performance
            9.17.4 Bio Elpida Business Overview
            9.17.5 Bio Elpida Recent Developments
      9.18 Genezen
            9.18.1 Genezen Basic Information
            9.18.2 Genezen Cell Therapy Cdmo Product Overview
            9.18.3 Genezen Cell Therapy Cdmo Product Market Performance
            9.18.4 Genezen Business Overview
            9.18.5 Genezen Recent Developments
      9.19 CCRM
            9.19.1 CCRM Basic Information
            9.19.2 CCRM Cell Therapy Cdmo Product Overview
            9.19.3 CCRM Cell Therapy Cdmo Product Market Performance
            9.19.4 CCRM Business Overview
            9.19.5 CCRM Recent Developments
      9.20 RoslinCT
            9.20.1 RoslinCT Basic Information
            9.20.2 RoslinCT Cell Therapy Cdmo Product Overview
            9.20.3 RoslinCT Cell Therapy Cdmo Product Market Performance
            9.20.4 RoslinCT Business Overview
            9.20.5 RoslinCT Recent Developments
      9.21 GenScript ProBio
            9.21.1 GenScript ProBio Basic Information
            9.21.2 GenScript ProBio Cell Therapy Cdmo Product Overview
            9.21.3 GenScript ProBio Cell Therapy Cdmo Product Market Performance
            9.21.4 GenScript ProBio Business Overview
            9.21.5 GenScript ProBio Recent Developments
  10 Cell Therapy Cdmo Market Forecast by Region
      10.1 Global Cell Therapy Cdmo Market Size Forecast
      10.2 Global Cell Therapy Cdmo Market Forecast by Region
            10.2.1 North America Market Size Forecast by Country
            10.2.2 Europe Cell Therapy Cdmo Market Size Forecast by Country
            10.2.3 Asia Pacific Cell Therapy Cdmo Market Size Forecast by Region
            10.2.4 South America Cell Therapy Cdmo Market Size Forecast by Country
            10.2.5 Middle East and Africa Forecasted Sales of Cell Therapy Cdmo by Country
  11 Forecast Market by Type and by Application (2026-2033)
      11.1 Global Cell Therapy Cdmo Market Forecast by Type (2026-2033)
      11.2 Global Cell Therapy Cdmo Market Forecast by Application (2026-2033)
  12 Conclusion and Key Findings
Charles River
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400